skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

About John

{A1EF0A44-49EE-467F-964C-F748991F5552}

+12 year(s) experience

John Davis
John writes news and analysis about European biotech and pharma companies, including their product development, marketing, financial prospects and personnel.
A biochemical pharmacologist by training, John observes and describes the way European biotech and pharmaceutical companies are in the business of trying to triumph over poor health and disease. He has an intense interest in how medicines work, what drives their development, and the business strategies of the companies involved, including their inter-company collaborations, their ability to raise financing, revenues and income, and moves to provide a return to investors, within the context of marketing medicines. He interviews company executives and entrepreneurs for insights and background to produce forward-looking news and analysis, in-depth reports, and market commentary. In his spare time, John is a DIY enthusiast and a member of the RSPB and the National Trust.

Analyst Articles

Articles by John